Q2FY23 Preview: Apollo Hospitals Enterprise: Revenue seen at Rs41,154 million, PAT at Rs2,326 million

9 Nov 2022 , 03:06 PM

Result date: 10^th November, 2022
Recommendation: Buy
Target price: Rs4,815
(Source: IIFL Research)
 
For the September 2022 quarter, Apollo Hospitals Enterprise (Apollo Hospitals) could witness sequential improvement in occupancy. Strong growth in standalone pharmacies and double digit growth in AHLL could drive ~11% year-on-year growth in revenue.

Continued losses in the 24×7 segment could hit overall profitability of the company. Excluding these, EBITDA could grow in mid-single digits.

Apollo Hospitals could report a 6% drop in its Profit After Tax (PAT) over the year-ago quarter.

Important management insights to watch out for:

• Growth outlook for key business segments
• Spends towards 24/7 (digital health platform) and its breakeven

Rs. Million	September 2022 estimates	QoQ change	YoY change
Revenue	41,154	8.43%	10.70%
EBITDA	5,711	16.37%	(7.10)%
Profit After Tax	2,326	(7.37)%	(6.13)%

Source: Brokerage Reports